203 related articles for article (PubMed ID: 18069753)
1. Telbivudine: a new treatment for chronic hepatitis B.
Amarapurkar DN
World J Gastroenterol; 2007 Dec; 13(46):6150-5. PubMed ID: 18069753
[TBL] [Abstract][Full Text] [Related]
2. Telbivudine: a new option for the treatment of chronic hepatitis B.
Ruiz-Sancho A; Sheldon J; Soriano V
Expert Opin Biol Ther; 2007 May; 7(5):751-61. PubMed ID: 17477811
[TBL] [Abstract][Full Text] [Related]
3. A review of telbivudine for the management of chronic hepatitis B virus infection.
Lui YY; Chan HL
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1351-61. PubMed ID: 18798704
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B.
Wiens A; Venson R; Correr CJ; Pontarolo R
Braz J Infect Dis; 2011; 15(3):225-30. PubMed ID: 21670922
[TBL] [Abstract][Full Text] [Related]
5. Telbivudine: a novel nucleoside analog for chronic hepatitis B.
Kim JW; Park SH; Louie SG
Ann Pharmacother; 2006 Mar; 40(3):472-8. PubMed ID: 16507625
[TBL] [Abstract][Full Text] [Related]
6. Treating chronic hepatitis B: today and tomorrow.
Borgia G; Gentile I
Curr Med Chem; 2006; 13(23):2839-55. PubMed ID: 17073632
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial.
Chan HL; Heathcote EJ; Marcellin P; Lai CL; Cho M; Moon YM; Chao YC; Myers RP; Minuk GY; Jeffers L; Sievert W; Bzowej N; Harb G; Kaiser R; Qiao XJ; Brown NA;
Ann Intern Med; 2007 Dec; 147(11):745-54. PubMed ID: 17909201
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis B: focus on telbivudine.
Lui YY; Chan HL
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
[TBL] [Abstract][Full Text] [Related]
9. Telbivudine: a review of its use in compensated chronic hepatitis B.
McKeage K; Keam SJ
Drugs; 2010 Oct; 70(14):1857-83. PubMed ID: 20836578
[TBL] [Abstract][Full Text] [Related]
10. [New treatment of chronic hepatitis B].
Andersen ES; Weis NM
Ugeskr Laeger; 2008 Nov; 170(48):3937-9. PubMed ID: 19087730
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
Moon YM; Hwang SG; Kim BS; Rim KS; Cho M; Kim DJ; Han JY; Kim YS; Choi HS; Ahn SH
Korean J Hepatol; 2007 Dec; 13(4):503-12. PubMed ID: 18159148
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic hepatitis B: will entecavir and telbivudine do the trick?
Anand AC; Puri P
Trop Gastroenterol; 2008; 29(2):71-5. PubMed ID: 18972765
[TBL] [Abstract][Full Text] [Related]
13. Telbivudine for the treatment of chronic hepatitis B infection.
Hartwell D; Jones J; Harris P; Cooper K
Health Technol Assess; 2009 Oct; 13 Suppl 3():23-30. PubMed ID: 19846025
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review].
Almeida AM; Ribeiro AQ; Pádua CA; Brandão CM; Andrade EI; Cherchiglia ML; Carmo RA; Acurcio Fde A
Rev Soc Bras Med Trop; 2010; 43(4):440-51. PubMed ID: 20802947
[TBL] [Abstract][Full Text] [Related]
15. New drugs for chronic hepatitis B: a review.
Palumbo E
Am J Ther; 2008; 15(2):167-72. PubMed ID: 18356637
[TBL] [Abstract][Full Text] [Related]
16. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
17. Telbivudine.
Keam SJ
Drugs; 2007; 67(13):1917-29. PubMed ID: 17722961
[TBL] [Abstract][Full Text] [Related]
18. Current status of nucleoside antivirals in chronic hepatitis B.
Duong A; Mousa SA
Drugs Today (Barc); 2009 Oct; 45(10):751-61. PubMed ID: 20069139
[TBL] [Abstract][Full Text] [Related]
19. Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.
Han SH
Expert Opin Investig Drugs; 2005 Apr; 14(4):511-9. PubMed ID: 15882124
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis.
Wu B; Li T; Chen H; Shen J
Value Health; 2010 Aug; 13(5):592-600. PubMed ID: 20561341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
